Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2030

14 Feb 2023
www.prnewswire.com
NEW YORK, Feb. 14, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Continue Reading
Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2030
Preview
Source: PRNewswire
Read the full report: https://www.reportlinker.com/p03646062/?utm_source=PRN
Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Commercial Biotechnology Separation Systems estimated at US$24.6 Billion in the year 2022, is projected to reach a revised size of US$31 Billion by 2030, growing at aCAGR of 2.9% over the period 2022-2030. Conventional, one of the segments analyzed in the report, is projected to record 2.7% CAGR and reach US$19 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Modern segment is readjusted to a revised 3.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 4.8% CAGR
The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 2.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.
Select Competitors (Total 46 Featured)
- Alfa Wassermann Separation Technologies LLC
- Flottweg SE
- Merck KGaA
- Sartorius Stedim Biotech SA
- Thermo Fischer Scientific Inc.
Read the full report: https://www.reportlinker.com/p03646062/?utm_source=PRN
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Separation Technologies Drive Biotechnology Industry
Recent Market Activity
Developed Markets Lead the Way while Emerging Markets Promise
Growth
DNA Microarrays - Largest & Fastest Growing Segment
Liquid Chromatography - One of the Leading Biotechnology
Factors Sustaining Market Growth
Factors Restraining Growth
Commercial Biotechnology Separation Systems - Global Key
Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3M (USA)
Alfa Laval AB (Sweden)
Alfa Wassermann Separation Technologies, LLC (USA)
Becton, Dickinson and Company (USA)
Flottweg SE (Germany)
Groupe Novasep (France)
Merck KGaA (Germany)
SEPMAG (Spain)
3. MARKET TRENDS & DRIVERS
Bioseparation Systems - Invaluable Tools in Biopharmaceutical
Manufacturing
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products - An Overview
Surging Biopharmaceutical Market Spurs Demand for Bioseparation
Systems
New Biologic License Application (BLA) Approvals: 2017
New Biologic License Application (BLA) Approvals: 2016
New Biologic License Application (BLA) Approval: 2015
Evolving Biopharmaceutical Industry Emphasizes on Novel
Technologies
Increasing Emphasis on Personalized Medicine Drives Market Growth
Rise in Healthcare Spending Bodes Well for Market Growth
Aging Population Drives Biotechnology Separation Systems Market
Global Aging Population Statistics - Opportunity Indicators
Increasing Incidence of Cancer Drives Biotechnology Separation
Systems Market
Increasing Competition Spurs Renewed Focus on Efficiencies
Growing Orphan Drugs Market Draws Attention towards
Manufacturing Flexibility
Downstream Processing - A Major Trend among Biopharmaceutical
Manufacturers
Upstream and Downstream Mismatch Turns Focus towards Innovative
Technologies
Protein Separation in Biopharmaceutical Space Assumes Greater
Significance
Growing Market for Monoclonal Antibodies - A Key Review of
Current Status and Future Prospects
Approved Monoclonal Antibodies: 2014-2017
An Insight into Bioseparation of mAbs
Market Potential for Biosimilars - A Case for Substantial
US Approved Biosimilars as of December 2017
Europe Approved Biosimilars as of December 2017
Patent Expiries Create Opportunities for Biosimilar Manufacturers
Patent Expiries of Major Biologics in the US and Europe
Huge Biopharmaceutical Pipeline - A Clear Indicator of Future
Prospects
Disposables to Infuse Cost Effectiveness in Biopharmaceutical
Production
Single-Use Products Gain Significant Attention
Market Prospects for Single-Use Disposable Technologies
Select Commercial Disposable/Single-Use Technologies by Process
Technique
Innovations in Single-use Systems
Modular Bioprocessing - An Emerging Trend
Leachables and Extractables Trounce Enthusiasm around Disposables
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR
Table 2: World Historic Review for Commercial Biotechnology
Separation Systems by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2021 and % CAGR
Table 3: World 18-Year Perspective for Commercial Biotechnology
Separation Systems by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Conventional by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Conventional by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR
Table 6: World 18-Year Perspective for Conventional by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Modern by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Modern by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR
Table 9: World 18-Year Perspective for Modern by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Pharmaceutical by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Pharmaceutical by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 12: World 18-Year Perspective for Pharmaceutical by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for Food &
Cosmetics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Food & Cosmetics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 15: World 18-Year Perspective for Food & Cosmetics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Agriculture by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR
Table 18: World 18-Year Perspective for Agriculture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 21: World 18-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030
Table 22: World Commercial Biotechnology Separation Systems
Market Analysis of Annual Sales in US$ Million for Years 2012
through 2030
III. MARKET ANALYSIS
UNITED STATES
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in the United
States for 2023 (E)
Table 23: USA Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 24: USA Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 25: USA 18-Year Perspective for Commercial Biotechnology
Separation Systems by Method - Percentage Breakdown of Value
Sales for Conventional and Modern for the Years 2012, 2023 &
2030
Table 26: USA Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 27: USA Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 28: USA 18-Year Perspective for Commercial Biotechnology
Separation Systems by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical, Food & Cosmetics, Agriculture and
Other End-Uses for the Years 2012, 2023 & 2030
CANADA
Table 29: Canada Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 30: Canada Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 31: Canada 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 32: Canada Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 33: Canada Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 34: Canada 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
JAPAN
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Japan for
2023 (E)
Table 35: Japan Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 36: Japan Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 37: Japan 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 38: Japan Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 39: Japan Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 40: Japan 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
CHINA
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in China for
2023 (E)
Table 41: China Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 42: China Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 43: China 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 44: China Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 45: China Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 46: China 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
EUROPE
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Europe for
2023 (E)
Table 47: Europe Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 48: Europe Historic Review for Commercial Biotechnology
Separation Systems by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 49: Europe 18-Year Perspective for Commercial
Biotechnology Separation Systems by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets for Years 2012,
2023 & 2030
Table 50: Europe Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 51: Europe Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 52: Europe 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 53: Europe Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 54: Europe Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 55: Europe 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
FRANCE
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in France for
2023 (E)
Table 56: France Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 57: France Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 58: France 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 59: France Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 60: France Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 61: France 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
GERMANY
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Germany for
2023 (E)
Table 62: Germany Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 63: Germany Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 64: Germany 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 65: Germany Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 66: Germany Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 67: Germany 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
ITALY
Table 68: Italy Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 69: Italy Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 70: Italy 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 71: Italy Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 72: Italy Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 73: Italy 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
UNITED KINGDOM
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in the United
Kingdom for 2023 (E)
Table 74: UK Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 75: UK Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 76: UK 18-Year Perspective for Commercial Biotechnology
Separation Systems by Method - Percentage Breakdown of Value
Sales for Conventional and Modern for the Years 2012, 2023 &
2030
Table 77: UK Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 78: UK Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 79: UK 18-Year Perspective for Commercial Biotechnology
Separation Systems by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical, Food & Cosmetics, Agriculture and
Other End-Uses for the Years 2012, 2023 & 2030
SPAIN
Table 80: Spain Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 81: Spain Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 82: Spain 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 83: Spain Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 84: Spain Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 85: Spain 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
RUSSIA
Table 86: Russia Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 87: Russia Historic Review for Commercial Biotechnology
Separation Systems by Method - Conventional and Modern Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 88: Russia 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 89: Russia Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 90: Russia Historic Review for Commercial Biotechnology
Separation Systems by End-Use - Pharmaceutical, Food &
Cosmetics, Agriculture and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2021 and % CAGR
Table 91: Russia 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
REST OF EUROPE
Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 93: Rest of Europe Historic Review for Commercial
Biotechnology Separation Systems by Method - Conventional and
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2021 and % CAGR
Table 94: Rest of Europe 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 95: Rest of Europe Recent Past, Current & Future Analysis
for Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 96: Rest of Europe Historic Review for Commercial
Biotechnology Separation Systems by End-Use - Pharmaceutical,
Food & Cosmetics, Agriculture and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 97: Rest of Europe 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
ASIA-PACIFIC
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific
for 2023 (E)
Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Commercial Biotechnology Separation Systems by Geographic
Region - Australia, India, South Korea and Rest of Asia-Pacific
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 99: Asia-Pacific Historic Review for Commercial
Biotechnology Separation Systems by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 100: Asia-Pacific 18-Year Perspective for Commercial
Biotechnology Separation Systems by Geographic Region -
Percentage Breakdown of Value Sales for Australia, India, South
Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 &
2030
Table 101: Asia-Pacific Recent Past, Current & Future Analysis
for Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 102: Asia-Pacific Historic Review for Commercial
Biotechnology Separation Systems by Method - Conventional and
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2021 and % CAGR
Table 103: Asia-Pacific 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 104: Asia-Pacific Recent Past, Current & Future Analysis
for Commercial Biotechnology Separation Systems by End-Use -
Pharmaceutical, Food & Cosmetics, Agriculture and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 105: Asia-Pacific Historic Review for Commercial
Biotechnology Separation Systems by End-Use - Pharmaceutical,
Food & Cosmetics, Agriculture and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR
Table 106: Asia-Pacific 18-Year Perspective for Commercial
Biotechnology Separation Systems by End-Use - Percentage
Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,
Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
AUSTRALIA
Commercial Biotechnology Separation Systems Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Australia for
2023 (E)
Table 107: Australia Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by Method -
Conventional and Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 108: Australia Historic Review for Commercial
Biotechnology Separation Systems by Method - Conventional and
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2021 and % CAGR
Table 109: Australia 18-Year Perspective for Commercial
Biotechnology Separation Systems by Method - Percentage
Breakdown of Value Sales for Conventional and Modern for the
Years 2012, 2023 & 2030
Table 110: Australia Recent Past, Current & Future Analysis for
Commercial Biotechnology Separation Systems by End-Use -
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p03646062/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.